- Breast Cancer
- Hot Flashes
(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:
To qualify for this trial, you must be at least 18 and have histologically or cytologically confirmed adenocarcinoma of the breast. Scans used to document measurable or evaluable disease must be done within four weeks of study entry.
The research site is in Anchorage, Ala.
This study will evaluate an investigational medication for hot flashes.
The research site is in Atlanta, Ga.
If you have severe emphysema in most of both lungs, are age 35 or older, willing to stop smoking at least eight weeks before entering the trial, have post-bronchodilator RV/TLC ratio of at least 0.65 and post-bronchodilator forced expiratory volume of less than 50 percent, you may qualify for this study.
The research site is in Denver, Colo.
Copyright 2008 CenterWatch. All rights reserved.
Copyright © 2011 HealthDay. All rights reserved.